Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Avenir Wellness Solutions, Inc. (AVRW)
Sherman Oaks, CA, US
Avenir Wellness Solutions, Inc., operating through its subsidiary The Sera Labs, Inc., specializes in crafting advanced nutraceutical formulations and innovative delivery technologies. Their objective is to maximize product effectiveness and enhance overall well-being. The company offers a diverse range of products across the beauty, health and wellness, and pet care segments, sold under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brands. Distribution channels include major drugstores, supermarkets, convenience stores, and mass retailers. Additionally, Avenir Wellness Solutions supplies products under private labels to other retailers and multi-level marketing firms, and directly to consumers online, including through subscription services. Established in 2014, the company was formerly known as CURE Pharmaceutical Holding Corp. before adopting its current name in October 2022. Its corporate headquarters are located in Sherman Oaks, California.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +100.00% | -33.33% | +19,900.00% | +0.00% | -33.33% | -50.00% | -98.46% | -99.85% | -99.97% | -99.99% | -99.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Packaged Foods: +4.4%-11.2% Q3'24: -81.1% (vs Q3'23)
-
EPS growth Packaged Foods: +14.6%+86.7% ★ Q3'24: +77.6% (vs Q3'23)
-
FCF margin FCF growth · Packaged Foods: +15.9%-46.7% Q3'24: -46.4% (vs Q3'23)
-
EBIT margin Packaged Foods: +7.9%-77.9% Q3'24: -271.9% (vs Q3'23)
-
ROIC Packaged Foods: +7.0%— Q3'24: +56.5% (vs Q3'23)
-
Share dilution Packaged Foods: +0.0%+2.7% Q3'24: +8.6% (vs Q3'23)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×-2.59× Q3'24: -4.40× (vs Q3'23)
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010-10-07 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 224,472 | 26.20 | 5.88M | 560,252 | — | ↗ |
| 2010-10-06 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 500 | 32.13 | 16.1K | 784,724 | — | ↗ |
| 2010-10-05 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 100,475 | 26.00 | 2.61M | 785,224 | — | ↗ |
| 2010-10-04 | WHITEBOX ADVISORS LLC | 10% Owner | J-Other | A | Common Stock | 1,958 | 0.00 | — | 885,699 | — | ↗ |
| 2010-09-22 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 24,000 | 24.29 | 583.0K | 907,741 | — | ↗ |
| 2010-09-13 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 200 | 23.05 | 4.6K | 907,741 | — | ↗ |
| 2010-08-23 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 50,000 | 26.05 | 1.30M | 907,941 | — | ↗ |
| 2010-08-16 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 200 | 27.50 | 5.5K | 927,941 | — | ↗ |
| 2010-08-12 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 200 | 27.50 | 5.5K | 928,141 | — | ↗ |
| 2010-07-26 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 10,000 | 30.00 | 300.0K | 928,141 | — | ↗ |
| 2010-07-07 | WHITEBOX ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 41,778 | 0.00 | — | 938,341 | — | ↗ |
| 2010-06-24 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 1,500 | 32.09 | 48.1K | 896,563 | — | ↗ |
| 2010-06-23 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 4,000 | 32.09 | 128.4K | 898,063 | — | ↗ |
| 2010-06-21 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 50,000 | 32.50 | 1.63M | 902,063 | — | ↗ |
| 2010-06-18 | WHITEBOX ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 101,153 | 32.13 | 3.25M | 952,063 | — | ↗ |
| 2010-03-31 | WHITEBOX ADVISORS LLC | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,053,216 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joel Bennett | Chief Financial Officer, Chief Accounting Officer, Secretary, Treasurer & Interim Chief Executive Officer | 220.0K | male |
| Robert Davidson | Founder, Chief Scientist & Chairman of the Board | 40.0K | male |
| Bhaumik Patel | Director of New Technologies | — | male |
| Rahul Dixit | Chief Medical Officer & Member of Medical Advisory Board | — | — |
| Rick Petry | Senior Vice President & Executive Creative Director | — | male |
| Patricia Hess | Chief Operating Officer | — | female |
| John Cammarano Jr. | Senior Vice President of Sales | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AVRW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
